Speeding Therapeutics towards First-in-Human Trials for Nervous System Disorders: A Workshop

Workshop

Accelerating Therapeutic Development for Nervous System Disorders towards First-in-Human Trials: A Workshop

April 8 - 9, 2013

Past

Agenda

About

On April 8-9, 2013, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop Accelerating Therapeutic Development for Nervous System Disorders towards First-in-Human Trials. This workshop explored opportunities to hasten the pathway from discovery to approval of the new therapeutics for nervous system disorders.

Invited presentations and discussions were designed to:

Examine opportunities and challenges in neuroscience research for facilitating faster entry of potential treatments into first-in-human trials.
- Discuss the role of new and emerging tools and technologies in accelerating therapeutic development.
- Identify avenues for developing integrated strategies that utilize both animal and non-animal models.
- Discuss potential benefits and risks of such an approach.
Explore how emerging neuroscience technologies and techniques may improve the efficiency of research and facilitate a more effective and efficient pathway to first-in-human trials (e.g. iPSCs, in vitro neuronal circuits, connectomics, brain imaging, etc.)
Consider regulatory mechanisms that may facilitate faster entry of potential treatments into first-in-human trials.
- Discuss how new and emerging tools and technologies may accelerate progress towards first-in-human trials.
Consider mechanisms for integration and proliferation of new technologies and techniques to facilitate drug development and discovery.

Contact

Contact us

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

Speeding Therapeutics towards First-in-Human Trials for Nervous System Disorders: A Workshop

Dropdown items

Accelerating Therapeutic Development for Nervous System Disorders towards First-in-Human Trials: A Workshop